Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an investigational drug, for the treatment of Lupus Nephritis (LN) and focal segmental glomerulosclerosis (FSGS). Additionally, we are advancing voclosporin ophthalmic solution (VOS), a topical formulation, for the treatment of dry eye syndrome (DES).

Aurinia is seeking a Manager of Financial Planning and Analysis (FP&A) to join the growing Finance team. The Manager of FP&A will report to the VP of FP&A and will provide strong financial planning and business partnering support for Aurinia’s Corporate G&A and Supply Chain teams. This role will serve as the main finance point of contact to the functions within the G&A and Supply Chain organization and will support the teams in the following: developing and managing the annual budget, budget to actual monthly reporting, reviewing and supporting the rolling forecast process and the long-term planning process and providing day-to-day operational support and ad-hoc strategic analysis. This position will also support the VP of FP&A in the overall consolidation and presentation of the budget and forecast and will play a key role in the ground-up design and implementation of a new financial planning and reporting system. This position will also play a role in the implementation of a supply chain accounting system. The ideal candidate for this role will have experience in a fast-paced high growth environment as Aurinia approaches commercialization. The position will require a hands-on individual who can interface with all levels of the company in a collaborative manner.

Primary Responsibilities

• Serve as the lead finance business partner to the G&A and Supply Chain teams and work with department heads to prepare the annual budget and quarterly rolling forecasts
• Lead the monthly analysis for the G&A and Supply Chain groups of financial results versus budget and forecast and investigate significant variances, communicating findings to departments and management
• Lead the overall consolidation and analysis of the annual budget and quarterly rolling forecast, including the preparation of the consolidated P&L and consolidated cash flow outlook
• Assist in preparing full financial packages for the Audit Committee and BoD meetings on a quarterly basis
• Provide daily operational support to the key internal stakeholders within Supply Chain, BD, Legal, IT, HR, Finance, Strategy and Corporate Communications
• Work closely with HR on companywide headcount planning
• Serve as a key team member supporting the VP of FP&A in designing and implementing a financial planning and reporting system and the design and implementation of a supply chain accounting system
• Assist in developing value-added internal management reporting to support better decision making
• Assess and anticipate department head needs and identify new opportunities
• Review G&A contracts for financial terms and manage associated monthly contract accruals

• Minimum BS in Accounting or Finance, CPA strongly preferred
• Minimum 7-10 years of successive experience across various financial disciplines with at least 5 consecutive years of recent strong FP&A experience
• Minimum of 5 years recent experience within the pharmaceutical industry is strongly preferred
• Experience in rolling forecasts
• Strong systems implementation experience and a demonstrated power-user in financial systems
• Effective presentation skills
• Strong written and verbal communication skills
• Great listening and collaboration skills
• Solutions oriented problem solver
• Solid business acumen
• Ability to deal with ambiguity and deal with complex issues
• Team utility player with the ability to toggle quickly from one project to another with ease and minimal direction
• Ability to work cross functionally and cross culturally
• Ability to travel approximately 5-10% of the time to Victoria, BC or Edmonton, Alberta

All candidate information will be kept confidential according to EEO guidelines.